Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Shimizu

Showing results (321-330 of 347) with videos related to

Pageof 35
Sort By:
Cancer Reports (Hoboken, N.J.)|July 30, 2021
Concordance of human equilibrative nucleoside transporter-1 expressions between murine (10D7G2) and rabbit (SP120) antibodies and association with clinical outcomes of adjuvant chemotherapy for pancreatic cancer: A collaborative study from the JASPAC 01 trialYukiyasu Okamura, Narikazu Boku, Paula Ghaneh, et al.
Cancer Science|November 29, 2019
Human equilibrative nucleoside transporter-1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S-1 chemotherapyYukiyasu Okamura, Satoru Yasukawa, Hiroto Narimatsu, et al.
The Journal of Medical Investigation : JMI|March 30, 2018
Combined resection of re-recurrent lateral lymph nodes and external iliac vein:Case Report and LiteratureKoji Komori, Takashi Kinoshita, Taihei Oshiro, et al.
Pancreas|December 28, 2020
Tolerability of Nab-Paclitaxel Plus Gemcitabine as Adjuvant Setting in Japanese Patients With Resected Pancreatic Cancer: Phase I StudyMakoto Ueno, Soichiro Morinaga, Yusuke Hashimoto, et al.
Anticancer Research|November 1, 2023
Novel Ureteral Stent Catheterization Technique for Treating Hyperchloremic Metabolic Acidosis After Total Pelvic ExenterationKoji Komori, Tsutomu Tanaka, Yoshitaka Inaba, et al.
Anticancer Research|June 26, 2024
Combined Pubic Arch and Ischial Bone Resection for Metachronous and Frequent Local Recurrences of Rectal CancerKoji Komori, Masahiro Yoshida, Satoshi Tsukushi, et al.
The American Surgeon|August 30, 2022
Total Pelvic Exenteration Combined With Sacral Resection for Rectal CancerKoji Komori, Satoshi Tsukushi, Masahiro Yoshida, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|December 12, 2023
Is preoperative pancreatic juice cytology useful for determining therapeutic strategies for patients with intraductal papillary mucinous neoplasm of the pancreas?Rintaro Nagayama, Toshiharu Ueki, Yasuhiro Shimizu, et al.
Cancers|July 24, 2021
Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal CancerDelphine Dayde, Jillian Gunther, Yutaka Hirayama, et al.
Surgery Today|April 10, 2019
Prognostic predictions based on pathological findings of peritoneal dissemination in patients with stage IV colorectal cancer without residual disease (R0 status)Koji Komori, Takashi Kinoshita, Taihei Oshiro, et al.
Pageof 35

Showing results (321-330 of 347) with videos related to

Sort By:
Pageof 35
Cancer Reports (Hoboken, N.J.)|July 30, 2021
Concordance of human equilibrative nucleoside transporter-1 expressions between murine (10D7G2) and rabbit (SP120) antibodies and association with clinical outcomes of adjuvant chemotherapy for pancreatic cancer: A collaborative study from the JASPAC 01 trialYukiyasu Okamura, Narikazu Boku, Paula Ghaneh, et al.
Cancer Science|November 29, 2019
Human equilibrative nucleoside transporter-1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S-1 chemotherapyYukiyasu Okamura, Satoru Yasukawa, Hiroto Narimatsu, et al.
The Journal of Medical Investigation : JMI|March 30, 2018
Combined resection of re-recurrent lateral lymph nodes and external iliac vein:Case Report and LiteratureKoji Komori, Takashi Kinoshita, Taihei Oshiro, et al.
Pancreas|December 28, 2020
Tolerability of Nab-Paclitaxel Plus Gemcitabine as Adjuvant Setting in Japanese Patients With Resected Pancreatic Cancer: Phase I StudyMakoto Ueno, Soichiro Morinaga, Yusuke Hashimoto, et al.
Anticancer Research|November 1, 2023
Novel Ureteral Stent Catheterization Technique for Treating Hyperchloremic Metabolic Acidosis After Total Pelvic ExenterationKoji Komori, Tsutomu Tanaka, Yoshitaka Inaba, et al.
Anticancer Research|June 26, 2024
Combined Pubic Arch and Ischial Bone Resection for Metachronous and Frequent Local Recurrences of Rectal CancerKoji Komori, Masahiro Yoshida, Satoshi Tsukushi, et al.
The American Surgeon|August 30, 2022
Total Pelvic Exenteration Combined With Sacral Resection for Rectal CancerKoji Komori, Satoshi Tsukushi, Masahiro Yoshida, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|December 12, 2023
Is preoperative pancreatic juice cytology useful for determining therapeutic strategies for patients with intraductal papillary mucinous neoplasm of the pancreas?Rintaro Nagayama, Toshiharu Ueki, Yasuhiro Shimizu, et al.
Cancers|July 24, 2021
Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal CancerDelphine Dayde, Jillian Gunther, Yutaka Hirayama, et al.
Surgery Today|April 10, 2019
Prognostic predictions based on pathological findings of peritoneal dissemination in patients with stage IV colorectal cancer without residual disease (R0 status)Koji Komori, Takashi Kinoshita, Taihei Oshiro, et al.
Pageof 35